Adalimumab (brand names Humira, Amgevita, Hyrimoz, Idacio, Imraldi, and Yuflyma), which is used to treat conditions such as Crohn's disease and rheumatoid arthritis, targets and inhibits tumor necrosis factor-alpha (TNF-α). The gene discussed is TNF; the disease is rheumatoid arthritis.